Provides high-quality 3D imaging at 2D low-radiation doses
The Christine E. Lynn Women’s Health & Wellness Institute at
Boca Raton Regional Hospital is the first in Florida to offer SenoClaire™
three-dimensional breast tomosynthesis by GE Healthcare. The versatile
imaging technology provides mammograms with high resolution, low radiation
and excellent detection for patients with all types of breast tissues,
resulting in a more confident screening.
While other programs moved quickly to introduce first-generation technology, the Hospital waited until it could provide its patients with the latest in digital breast tomosynthesis. SenoClaire™ is the only 3D breast tomosynthesis approved by the U.S. Food and Drug Administration that delivers the same low dose as 2D screenings, with a 3D view dose at least 40 percent lower than other 3D mammography on the market.*
SenoClaire™ is also the only FDA-approved digital breast tomosynthesis to use a “step-and-shoot” method, a short X-ray sweep around the positioned breast, to acquire exposures. Since the tube comes to a complete stop when capturing each one of the nine exposures, this technique removes potential motion from the tube and helps reduce blur and increase image sharpness.
Moreover, the SenoClaire™ imaging technique separates tissues and reduces overlapping of structures, enabling better characterization of malignant and benign findings compared with traditional mammography. Our physicians believe that using 3D mammography can help improve cancer detection in patients with dense breasts. Common among women, dense breasts have more fibrous or glandular tissue versus fatty tissue. Though cancer is more likely to develop in dense breasts, 2D mammography may not always accurately detect it.
“We are pleased to bring our patients the latest in 3D mammography, advancing our ability to provide women with a more personalized and precise screening process,” said Kathy Schilling, MD, Medical Director of the Lynn Women’s Health & Wellness Institute. “As we know, there is a better rate of survival when cancer is discovered and treated early. This technology marks another significant step forward in enhancing our clinicians’ ability to detect masses and small microcalcifications, which can represent cancer at its most curable stage.”
*Leuven University: Application of the draft EUREF protocol for Quality
Control of digital breast tomosynthesis (DBT) systems, Marshall &
Bosmans (February 2014)
About Boca Raton Regional Hospital – Advancing the boundaries of medicine.
Boca Raton Regional Hospital is an advanced, tertiary medical center (BRRH.com) with 400 beds and more than 800 primary and specialty physicians on staff. The Hospital is a recognized leader in oncology, cardiovascular disease and surgery, minimally invasive surgery, orthopedics, women’s health, emergency medicine and the neurosciences, all of which offer state-of-the-art diagnostic and imaging capabilities. The Hospital is a designated Comprehensive Stroke Center by the Florida Agency for Health Care Administration (AHCA).
Boca Raton Regional Hospital is the recipient of the 2014 Distinguished Hospital Award for Clinical Excellence™ for the 10th year in a row and was named one of America’s 50 Best Hospitals in 2011, 2012, 2013 and 2014, both by Healthgrades®. Boca Raton Regional Hospital was also recognized for the third consecutive year in U.S. News & World Report’s 2013–2014 Best Hospitals listing as a top-ranked hospital in the South Florida metropolitan area.
Thomas Chakurda, 561.955.3586
Vice President, Marketing